Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01055717 · ClinicalTrials.gov registry record · NA

Bioavailability of Avenanthramide-Enriched Oats in Healthy Older Adults

A NA study of Healthy, sponsored by Tufts University.

Completed
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT01055717 is a NA study of Healthy that has completed, run by Tufts University. The registered enrollment target is 12 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01055717, a NA study of Healthy, has completed, sponsored by Tufts University.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

This is a placebo-controlled, crossover study investigating the pharmacokinetic bioavailability of avenanthramides from avenanthramide-enriched oats and their in vivo metabolites in a cohort of healthy, older adults.

Conditions Studied

Interventions

  • OTHER Avenanthramide-enriched oats

Study Locations (1)

Massachusetts

  • Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University - Boston

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2010-03
Est. Completion 2011-01
Phase NA

Sponsor

Tufts University

163 total trials

What the Registry Record Tells You About NCT01055717

The ClinicalTrials.gov registry entry for NCT01055717 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower). The listed sponsor is Tufts University, which has 163 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Avenanthramide-enriched oats is the first listed.

NCT01055717 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01055717 about?

NCT01055717 is a clinical study titled "Bioavailability of Avenanthramide-Enriched Oats in Healthy Older Adults". This is a placebo-controlled, crossover study investigating the pharmacokinetic bioavailability of avenanthramides from avenanthramide-enriched oats and their in vivo metabolites in a cohort of healthy, older adults.

What is the current status of trial NCT01055717?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2010-03. Estimated completion is 2011-01.

What conditions does trial NCT01055717 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT01055717?

The interventions under investigation include: Avenanthramide-enriched oats (OTHER).

Who is sponsoring clinical trial NCT01055717?

This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01055717 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.